Breast Cancer Research

Description

Breast Cancer

Search

Clinical Trials

Adjuvant Breast (EndoPredict Extended Endocrine Trial EXET Myriad)

STATUS: Active, Recruiting

Adjuvant (Alliance A011801 Compass HER2 Residual Disease)

STATUS: Active, Not Recruiting

City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives

STATUS: Active, Recruiting

Neoadjuvant (ECOG-ACRIN EA1181 Compass HER2 pCR)

STATUS: Active, Recruiting

TARGIT

STATUS: Active, Recruiting

View all Clinical Trials

Publications

Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer.

Engaging patients in decisions about cancer screening: exploring the decision journey through the use of a patient portal.

Breast cancer chemoprevention in primary care - assessing readiness for change.

Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach.

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?

View all Publications

Research Studies

Impact of COVID-19 on Cancer Care Management

Breast Cancer Chemoprevention in Primary Care at Geisinger

Dana Farber 13-09-259 DCIS Registry

All Research Studies

Featured Investigator

Deepti Behl

MD

Dr. Behl is a research physician at Sutter Institute for Medical Research (SIMR). Her research interests include Oncology research focusing on lung cancer.

Meet Deepti Behl

The Sutter Health Network of Care

Expertise to fit your needs

Check-ups, screenings and sick visits for adults and children.

Expertise and advanced technologies in all areas of medicine.

For serious accidents, injuries and conditions that require immediate medical care.

After-hours, weekend and holiday services.

Convenient walk-in care clinics for your non-urgent health needs.